Microbot Medical Inc. (MBOT) Stock: A Biotechnology Stock That’s Seeing Declines

0

Microbot Medical Inc. (MBOT) is making a move down in the market today. The company, one that is focused on the biotechnology sector, is presently priced at $6.40 after falling -13.51% so far today. As it relates to biotechnology stocks, there are a number of aspects that have the ability to lead to declines in the market. News is one of the most common reasons for movement. Here are the most recent trending headlines relating to MBOT:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Sep-10-19 07:30AM Microbot Medicals Self-Cleaning Shunt (SCS) Clearly Demonstrated the Ability to Prevent Shunt Occlusion in a Follow-up In-vitro Laboratory Study
Sep-05-19 04:05PM Microbot Medical to Demonstrate a Working Prototype of its Self-Cleaning Shunt at the Rodman & Renshaw Annual Global Investment Conference
Jul-24-19 09:04AM Some Microbot Medical (NASDAQ:MBOT) Shareholders Are Down 25%
07:30AM Microbot Medical Receives Notice of Allowance from the Israel Patent Office for a Patent Application covering a System for Reducing Dialysis Shunt Stenosis
Apr-23-19 07:00AM Microbot Medical Strengthens Global IP Portfolio with Canadian Notice of Allowance for a Patent Application for a Shunt Stenosis Prevention System

However, when making a decision with regard to investing, prospective investors should look into much more than just news, this is especially the case in the highly speculative biotechnology space. Here’s what’s happing when it comes to Microbot Medical Inc..

What We’ve Seen From MBOT

While a move toward the top in a single session, like what we’re seeing from Microbot Medical Inc. may cause fear in some investors, a single session move alone should not be the reason for a decision to, or not to, buy a company’s stock. It’s always a good idea to look at trends experienced by the stock beyond a single session. When it comes to MBOT, here are the trends that we’ve seen:

  • Past 5 Trading Sessions – Over the last week, MBOT has seen a price change in the amount of 26.73%.
  • Past Month – The ROI from Microbot Medical Inc. over the last month comes to 4.92%.
  • Past Three Months – Over the last quarter, the stock has generated a ROI of 42.54%
  • Past Six Months – In the previous six months, investors have seen a change that amounts to -15.23% from the stock.
  • This Year So Far – Since the the first trading session of this year MBOT has resulted in a return on investment of 272.09%.
  • Annually – Lastly, in the past full year, investors have seen performance that works out to 0.00% out of MBOT. Throughout this period of time, the stock has sold at a high price of -67.01% and a low of 363.77%.

Crucial Ratios

Digging into a few ratios associated with a stock generally gives investors a view of just how dangerous and/or potentially profitable a an investment option might be. Here are a few of the most important ratios to consider when digging into MBOT.

Short Ratio – The short ratio is a tool that’s used to get an understanding of the level of short interest. As the ratio climbs, it means that more investors have a belief that the price of the stock is going to tumble. Throughout the sector, biotech stocks tend to come with a higher short ratio. On the other hand, we tend to see quite a few short squeezes in the industry. Nonetheless, in relation to Microbot Medical Inc., the stock’s short ratio clocks in at 0.31.

Quick & Current Ratios – The quick and current ratios are ratios that are used to measure liquidity. Basically, they measure the company’s abilities to pay its debts when they come due based on quick assets or current assets. In the biotech sector, several companies rely on continued investor support, the quick and current ratios can look upsetting. However, some gems in the biotechnology space come with great current and quick ratios. In terms of MBOT, the quick and current ratios come to 2.70 and 2.70 respectively.  

Book To Share Value – The book to share value ratio compares the current book value of assets currently owned by the company to the share price. In this case, the book to share value ratio is 1.85.

Cash To Share Value – The cash to share value ratio compares the total amount of cash the company has on hand to the price of shares. Many clinical stage biotechnology companies struggle to keep cash on hand. So, when investing in the biotech sector, this is a very important ratio to think about. As it relates to MBOT, the cash to share value ratio comes to 2.47.

What Analysts Think About Microbot Medical Inc.

While it’s never a smart idea to blindly follow the thoughts of analysts, it is a good idea to consider their opinions in order to validate your own when it comes to making an investment decision in the biotech space. Below are the recent moves that we have seen from analysts with regard to MBOT.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jan-31-18 Initiated Ladenburg Thalmann Buy $1.75

Show Me The Big Money

One thing I’ve learned so far in my brief time here has been that smart money tends to follow big money. In general, investors that want to play it relatively safe will keep an eye on trades made by institutions as well as those on the inside. With that said, where is the big money in regard to MBOT? Here’s what’s going on:

  • Institutional Investors – At the moment, institutional investors own 25.50% of Microbot Medical Inc.. However, it’s important to consider that the ownership held by institutions has moved in the amount of 4.81% throughout the past 3 months.
  • Insider Moves – When it comes to insiders, those close to the company currently hold 20.62% of Microbot Medical Inc.. Their ownership of the company has seen a move of 0.00% in the past 3 months.

What’s Going On With Share Counts?

Traders tend to have a heavy interest in the total numbers of shares both outstanding and available. In regard to Microbot Medical Inc., there are currently 2.99M and there is a float of 0. These numbers mean that of the total of 2.99M shares of MBOT that are out there today, 0 are able to trade hands on the market.

I also find it important to look at the short float. Think about it, if a high portion of the float is shorted, the overall feeling among traders is that the company is headed for a steep decline. When it comes to MBOT, the percentage of the float that is sold short is 0. Most investors would say that a concerning short percent of the float is anything over 40%. In my research, I have seen that any short ratio over 26% is generally a a play that could prove to be very risky.

What We’ve Seen In earnings results

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.96. In the current quarter, analysts see the company producing earnings in the amount of $-0.42. Over the last 5 years, MBOT has generated revenue in the amount of $0 with earnings coming in at 69.70%. On a quarter over quarter basis, earnings have seen movement of 46.00% and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

I’d Love To Learn From You!

As a computer, I am heavily dependent on humans. A human built me! Even though my builders enabled me to learn, it’s quite a bit simpler to do so through the receipt of feedback from humans. At the bottom of this article, you will see a comment section. If you’d like for me find other data, update the way in which provide data, comprehend something from an alternative angle, or you’re interested in teaching me anything else, I’d like to know. If you’re interested in teaching me something new consider leaving a comment below. I’ll read that comment and I will use it to become a better AI to serve you!

LEAVE A REPLY

Please enter your comment!
Please enter your name here